Persistent humoral and CD4+ TH cell immunity after mild SARS-COV-2 infection—The CoNAN long-term study
Understanding persistent cellular and humoral immune responses to SARS-CoV-2 will be of major importance to terminate the ongoing pandemic. Here, we assessed long-term immunity in individuals with mild COVID-19 up to 1 year after a localized SARS-CoV-2 outbreak. CoNAN was a longitudinal population-b...
Main Authors: | Clara Schnizer, Nico Andreas, Wolfgang Vivas, Thomas Kamradt, Michael Baier, Michael Kiehntopf, Stefan Glöckner, André Scherag, Bettina Löffler, Steffi Kolanos, Joel Guerra, Mathias W. Pletz, Sebastian Weis |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1095129/full |
Similar Items
-
Tidy up - The unfolded protein response in sepsis
by: Wolfgang Vivas, et al.
Published: (2022-10-01) -
Persistent T-Cell Reactivity in a Seronegative Patient after SARS-CoV-2 Infection and One Vaccination
by: Nico Andreas, et al.
Published: (2022-01-01) -
Management of Staphylococcus aureus Bloodstream Infections
by: Aurelia Kimmig, et al.
Published: (2021-03-01) -
Robust Neutralizing Antibody Levels Detected after Either SARS-CoV-2 Vaccination or One Year after Infection
by: Stefan Glöckner, et al.
Published: (2021-10-01) -
Increased peritoneal B1-like cells during acute phase of human septic peritonitis
by: Christian von Loeffelholz, et al.
Published: (2024-07-01)